Back to Search
Start Over
H2O2/near-infrared light-responsive nanotheronostics for MRI-guided synergistic chemo/photothermal cancer therapy
- Source :
- Nanomedicine. 14:2189-2207
- Publication Year :
- 2019
- Publisher :
- Future Medicine Ltd, 2019.
-
Abstract
- Aim: To develop a H2O2/near-infrared (NIR) laser light-responsive nanoplatform (manganese-doped Prussian blue@polypyrrole [MnPB@PPy]) for synergistic chemo/photothermal cancer theranostics. Materials & methods: Doxorubicin (DOX) was loaded onto the surface of polypyrrole shells. The in vitro and in vivo MRI performance and anticancer effects of these nanoparticles (NPs) were evaluated. Results: The MnPB@PPy NPs could not only generate heat under NIR laser irradiation for cancer photothermal therapy but also act as an excellent MRI contrast agent. The loaded DOX could be triggered to release by both NIR light and H2O2 to enhance synergistic therapeutic efficacy. The antitumor effects were confirmed by in vitro cellular cytotoxicity assays and in vivo treatment in a xenograft tumor model. Conclusion: The designed H2O2/NIR light-responsive MnPB@PPy-DOX NPs hold great potential for future biomedical applications.
- Subjects :
- Near infrared light
Chemistry
MRI contrast agent
technology, industry, and agriculture
Biomedical Engineering
Cancer therapy
Medicine (miscellaneous)
Cancer
Bioengineering
02 engineering and technology
Development
Photothermal therapy
010402 general chemistry
021001 nanoscience & nanotechnology
medicine.disease
01 natural sciences
0104 chemical sciences
In vivo
medicine
Cancer research
General Materials Science
Doxorubicin
0210 nano-technology
Mri guided
medicine.drug
Subjects
Details
- ISSN :
- 17486963 and 17435889
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Nanomedicine
- Accession number :
- edsair.doi...........e0e8cba533106e08522c9f18522d640c